Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Breastfeed Med ; 19(5): 349-356, 2024 May.
Article in English | MEDLINE | ID: mdl-38469624

ABSTRACT

Background: Obesity is characterized as a low-grade chronic inflammatory state, marked by elevated inflammatory biomarkers. Breast milk (BM) is rich in nutritional elements, vitamins, minerals, immunological factors, and bioactive components. These bioactive components, capable of influencing biological processes, may vary in concentration based on maternal body composition. Research Aim/Question(s): This study aimed to explore the association between pro-inflammatory cytokine levels (interleukin-1 beta [IL-1ß], interleukin-6 [IL-6], and tumor necrosis factor-alpha [TNF-α]) in human colostrum and maternal body composition, as analyzed through bioelectrical impedance vector analysis (BIVA). Method: In this cross-sectional study, 117 healthy postpartum participants were included, with each group (normal weight, overweight, and obese) comprising 39 individuals, as classified by BIVA. Colostrum samples were collected within the first 24 hours postpartum. Results: IL-1ß levels did not significantly differ across the groups, with concentrations of 69.5 ± 103 pg/mL in normal-weight, 79.7 ± 97.9 pg/mL in overweight, and 68.7 ± 108 pg/mL in obese women. IL-6 levels were significantly higher in the overweight group (55 ± 72.4 pg/mL) than in the normal-weight (48.1 ± 74.1 pg/mL) and obese groups (28.9 ± 36.2 pg/mL) (p = 0.02). Similarly, TNF-α levels were higher in the overweight group, with concentrations of 58.7 ± 74.9 pg/mL, than in the normal-weight group, with concentrations of 38.6 ± 95.4 pg/mL, and 52.6 ± 115 pg/mL in obese women (p = 0.02). Conclusion: This study shows that IL-6 and TNF-α concentrations were statistically higher in the colostrum of overweight women, suggesting that maternal body composition may influence the inflammatory profile of BM.


Subject(s)
Body Composition , Colostrum , Interleukin-1beta , Interleukin-6 , Obesity , Postpartum Period , Tumor Necrosis Factor-alpha , Humans , Female , Colostrum/chemistry , Adult , Cross-Sectional Studies , Tumor Necrosis Factor-alpha/analysis , Tumor Necrosis Factor-alpha/metabolism , Interleukin-6/metabolism , Interleukin-6/analysis , Interleukin-1beta/analysis , Interleukin-1beta/metabolism , Obesity/metabolism , Overweight/metabolism , Pregnancy , Milk, Human/chemistry , Biomarkers/analysis , Young Adult
2.
Pigment Cell Melanoma Res ; 36(5): 388-398, 2023 09.
Article in English | MEDLINE | ID: mdl-37243929

ABSTRACT

Anti-programmed death-1 (anti-PD1) treatment has significantly improved outcomes of advanced melanoma with a considerable percentage of patients achieving complete response (CR). This real-world study analyzed the feasibility of elective anti-PD1 discontinuation in advanced melanoma patients with CR and evaluated factors related to sustained response. Thirty-five patients with advanced cutaneous or primary unknown melanoma with CR to nivolumab or pembrolizumab from 11 centers were included. Mean age was 66.5 years, and 97.1% had ECOG PS 0-1. 28.6% had ≥3 metastatic sites with 58.8% having M1a-M1b disease; 8.6% had liver and 5.7% had brain metastases. At baseline, 80% had normal LDH, and 85.7% had a neutrophil-to-lymphocyte ratio ≤3. 74.3% of patients had CR confirmed in PET-CT. Median duration of anti-PD1 was 23.4 months (range 1.3-50.5). 24 months after therapy discontinuation, 91.9% of patients were progression-free. Estimated PFS and OS at 36, 48, and 60 months from the start of anti-PD1 were 94.2%, 89.9%, 84.3%, and 97.1%, 93.3%, 93.3%, respectively. Antibiotics use after anti-PD1 discontinuation increased the odds of progression (OR 16.53 [95% CI 1.7, 226.03]). The study confirms the feasibility of elective anti-PD1 discontinuation in advanced melanoma patients with CR and favorable prognostic factors at baseline.


Subject(s)
Antineoplastic Agents, Immunological , Melanoma , Humans , Aged , Positron Emission Tomography Computed Tomography , Antineoplastic Agents, Immunological/therapeutic use , Antineoplastic Agents, Immunological/adverse effects , Melanoma/drug therapy , Melanoma/pathology , Nivolumab/therapeutic use , Cohort Studies , Retrospective Studies
3.
Chem Res Toxicol ; 33(8): 2157-2163, 2020 08 17.
Article in English | MEDLINE | ID: mdl-32618192

ABSTRACT

Recent reports have linked severe lung injuries and deaths to the use of e-cigarettes and vaping products. Nevertheless, the causal relationship between exposure to vaping emissions and the observed health outcomes remains to be elucidated. Through chemical and toxicological characterization of vaping emission products, this study demonstrates that during vaping processes, changes in chemical composition of several commonly used vape juice diluents (also known as cutting agents) lead to the formation of toxic byproducts, including quinones, carbonyls, esters, and alkyl alcohols. The resulting vaping emission condensates cause inhibited cell proliferation and enhanced cytotoxicity in human airway epithelial cells. Notably, substantial formation of the duroquinone and durohydroquinone redox couple was observed in the vaping emissions from vitamin E acetate, which may be linked to acute oxidative stress and lung injuries reported by previous studies. These findings provide an improved molecular understanding and highlight the significant role of toxic byproducts in vaping-associated health effects.


Subject(s)
Benzoquinones/adverse effects , Electronic Nicotine Delivery Systems , Hydroquinones/adverse effects , Lung Injury/chemically induced , Vaping/adverse effects , Vitamin E/adverse effects , Benzoquinones/chemistry , Benzoquinones/metabolism , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Hydroquinones/chemistry , Hydroquinones/metabolism , Vitamin E/chemistry , Vitamin E/metabolism
4.
Zootaxa ; 4731(3): zootaxa.4731.3.1, 2020 Feb 07.
Article in English | MEDLINE | ID: mdl-32230293

ABSTRACT

The diversity of free-living aquatic nematodes is largely unknown for the Gulf of Mexico and Caribbean Sea. The Cuban Archipelago is an important part of this because of its large area and diversity of habitats. We analyzed the free-living nematodes from 83 sites from seven aquatic habitats around Cuba, to produce a checklist for many habitats, including seagrass meadows, coral degradation zones, algal turf, bare sands, unvegetated muds, freshwater and anchihaline caves, and deep-sea sediments. The checklist contains 469 species, 229 genera, 50 families, and 9 orders. Chromadorida, Enoplida, and Monhysterida were the best represented orders with 112, 100, and 83 species respectively. The most abundant species were Euchromadora vulgaris, Terschellingia longicaudata, Desmodora pontica, Sabatieria pulchra , and Epsilonema sp. Most of the listed species were new records for the region. There were differences in the number of species recorded in each habitat type, with seagrass meadows having 280 species, coral degradation zones having 139 species, deep waters having 116 species, algal turf having 114 species, bare sands having 100 species, unvegetated muds having 78 species, freshwater caves having 19 species, anchihaline caves having 16 species, and freshwater streams having 6 species. The checklist is the most comprehensive recent report of the diversity of free-living nematodes in the regions of Gulf of Mexico and Caribbean Sea. The reported diversity is higher than many other regional checklists likely reflecting the intense sampling effort and the variety of microhabitats in Cuban Archipelago.


Subject(s)
Nematoda , Animals , Ecosystem
5.
Biodivers Data J ; 8: e58848, 2020.
Article in English | MEDLINE | ID: mdl-33390760

ABSTRACT

Diversity patterns of free-living marine nematodes in tropical seagrass beds are understudied. Here, we describe the species richness and assemblage composition of nematodes in 13 seagrass sites covering the whole Cuban archipelago. Nematodes were collected from Thalassia testudinum seagrass beds and identified to species level. We provide a checklist of nematode species from seagrass beds. The species richness of nematode assemblages is high, with 215 species, 138 genus, 35 families, seven orders and two classes. That γ-diversity is higher than other studies and points to seagrass beds as diversity hotspots of free-living marine nematodes. Local species richness in seagrass bed sites is about 57 ± 17 species and broadly similar across the sites, despite the environmental heterogeneity. The geographical distance plays a weak, but significant, role on the decay of similarity likely affected by limited dispersal of nematodes. The pairwise similarity values, related to poor-coloniser nematodes, were twice more affected by the distance than those related to good-colonisers, possibly due to differential success of transport and settlement.

6.
Rev Esp Salud Publica ; 86(5): 543-9, 2012 Oct.
Article in Spanish | MEDLINE | ID: mdl-23223766

ABSTRACT

BACKGROUND: Methadone programs have been organized in each Spanish region in a specific way. In spite of the regional interests to manage those programs in a more efficient way, so far the costs of the programs are unknown. As a previous step, it would be desirable to understand the activities related to these programs as well as their respective costs. This article aims to calculate the cost of the Methadone program in the autonomous community of La Rioja, and to understand those parameters which generate a greater cost to this programme. METHODS: The study followed a similar structure as the research recently applied to the region of Murcia. The reference year for the study of the annual costs of the Methadone program was 2010. Data were obtained from different registries of several institutions involved in the regional program. Costs were classified according to different stages and dispensation centres which participated in this programme. RESULTS: Data analysis, for a concentration of 2 mg/ml of methadone, showed an approximate annual cost of 165.759 euros. Taking the total number of patients into consideration the individual cost was 412,34 euros. CONCLUSIONS: Dispensation is the stage which caused the largest cost to the programme, the highest per patient cost corresponded to the centre with less patients due to the fact that fixed costs are shared by a smaller group of persons; the biggest global cost of the programme came from Logroño's center but its average cost is lower.


Subject(s)
Methadone/therapeutic use , Narcotics/therapeutic use , Opiate Substitution Treatment/economics , Adult , Costs and Cost Analysis , Drug Costs , Female , Humans , Methadone/economics , Middle Aged , Narcotics/economics , Program Evaluation , Spain
7.
Rev. esp. salud pública ; 86(5): 543-549, sept.-oct. 2012. tab
Article in Spanish | IBECS | ID: ibc-106822

ABSTRACT

Fundamento: Los programas de dispensación de metadona se han organizado en cada Comunidad Autónoma de una forma específica, desconociéndose sus costes derivados a pesar del interés que puede conllevar una gestión más eficiente. Nuestro estudio tiene por objetivo calcular los costes del programa de metadona en la ComunidadAutónoma de La Rioja. Métodos: El estudio se realizó en 2010. Los datos fueron recogidos a partir de los registros existentes en diferentes instituciones sanitarias, según las diferentes fases del programa. Los costes se clasificaron en función de las diferentes etapas y de los diferentes centros de dispensación. Resultados: El análisis de los datos muestra un coste total anual aproximado de 165.759 € para una concentración de 2 mg/ml de metadona, que significa un coste anual de 412,34 € por paciente . Conclusiones: La fase de dispensación de la metadona es la que mayor coste supone, el centro cuyos pacientes en términos relativos cuestan más al programa es el que cuenta con menor número de pacientes atendidos, debido a los costes fijos que han de repartirse entre menos personas, si bien el centro de Logroño tiene el mayor coste total por atender al mayor número de personas pero su coste medio por paciente es menor(AU)


Background: Methadone programs have been organized in each Spanish region in a specific way. In spite of the regional interests to manage those programs in a more efficient way, so far the costs of the programs are unknown. As a previous step, it would be desirable to understand the activities related to these programs as well as their respective costs. This article aims to calculate the cost of the Methadone program in the autonomous community of La Rioja, and to understand those parameters which generate a greater cost to this programme. Methods: The study followed a similar structure as the research recently applied to the region of Murcia. The reference year for the study of the annual costs of the Methadone program was 2010. Data were obtained fromdifferent registries of several institutions involved in the regional program. Costs were classified according to different stages and dispensation centres which participated in this programme. Results: Data analysis, for a concentration of 2 mg/ml of methadone, showed an approximate annual cost of 165.759 €. Taking the total number of patients into consideration the individual cost was 412,34€. Conclusions: Dispensation is the stage which caused the largest cost to the programme, the highest per patient cost corresponded to the centre with less patients due to the fact that fixed costs are shared by a smaller group of persons; the biggest global cost of the programme came from Logroño’s center but its average cost is lower(AU)


Subject(s)
Humans , Male , Female , Methadone/economics , Methadone/therapeutic use , Costs and Cost Analysis/methods , Costs and Cost Analysis/statistics & numerical data , Costs and Cost Analysis/trends , /standards , Drug Costs/statistics & numerical data , Drug Costs/trends , Costs and Cost Analysis/ethics , Costs and Cost Analysis/legislation & jurisprudence , Costs and Cost Analysis/standards , Drug Costs/ethics , Drug Costs/legislation & jurisprudence , Drug Costs/standards , Behind-the-Counter Drugs/economics
8.
Mar Environ Res ; 70(5): 374-82, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20828806

ABSTRACT

Marine nematodes from subtidal tropical sediments of Cienfuegos Bay were subjected to organic enrichment in a microcosm experiment for 32 days. Nematode abundance and diversity decreased, and the taxonomic and trophic structure was altered. The results suggested that the nematodes were not food limited in the microcosms or in their natural environment. Chemical stressors such as ammonia and hydrogen sulfide derived from reduced conditions in sediments may be important factors affecting the assemblages. Hypoxic conditions occurred in all experimental units, as well as in the field, suggesting a nematode assemblage adapted to naturally enriched sediments. However, tolerant species showed a grade of sensitivity to reduced conditions. In agreement with the model by Pearson and Rosenberg (1978), we predict that further organic enrichment in sediments from Cienfuegos Bay may cause a phase shift into a strongly depleted benthic fauna and reduced conditions in water and sediments.


Subject(s)
Environmental Monitoring , Nematoda/drug effects , Water Pollutants/toxicity , Animals , Biodiversity , Geologic Sediments/chemistry , Nematoda/classification , Water Pollutants/analysis
9.
Bioorg Med Chem Lett ; 18(14): 3848-51, 2008 Jul 15.
Article in English | MEDLINE | ID: mdl-18595695

ABSTRACT

A novel series of cyanoguanidine-piperazine P2X(7) antagonists were identified and structure-activity relationship (SAR) studies described. Compounds were assayed for activity at human and rat P2X(7) receptors in addition to their ability to inhibit IL-1 beta release from stimulated human whole blood cultures. Compound 27 possesses potent activity (0.12 microM) in this latter assay and demonstrates moderate clearance in-vivo.


Subject(s)
Guanidines/chemistry , Piperazines/chemistry , Purinergic P2 Receptor Antagonists , Animals , Chemistry, Pharmaceutical/methods , Drug Design , Humans , Inhibitory Concentration 50 , Interleukin-1beta/antagonists & inhibitors , Models, Chemical , Molecular Structure , Piperazine , Rats , Receptors, Purinergic P2/chemistry , Receptors, Purinergic P2X7 , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...